On October 20-21, 2015 in San Francisco, Portal Instruments will present at the 14th annual BIO Investor Forum. With a unique focus on venture-stage growth and emerging public companies, the forum offers an excellent opportunity for potential partnerships and business collaborations between over 360 biotech companies and the over 120 participating investors. Dr. Patrick Anquetil, Chief Executive Officer of Portal Instruments, will explain Portal’s innovative needle-free drug delivery device and its potential to improve patient experience, drug market penetration, enhance differentiation, and strengthen patient compliance. Dr. Anquetil will delve into the challenges inherent to injecting biologics that Portal’s connected device solves, including circumventing patients’ dislike for needles, decreasing injection duration, and providing connectivity for patients.
Learn more about the conference here.
Pages of the Portal Instruments website may contain links to third party websites that are not under the control of Portal Instruments. Portal Instruments is not responsible for the content of any such site and the inclusion of these links does not imply the endorsement of the content of the linked site by Portal Instruments.
Portal’s platform is in development and not available for sale or use.